• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Risk of dementia increased with gabapentin prescription in back pain patients

byPaary BalakumarandAlex Chan
July 17, 2025
in Chronic Disease, Neurology, Rheumatology
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. Gabapentin use was associated with a 29% increased risk of dementia and 85% increased risk of mild cognitive impairment (MCI) in chronic low back pain patients.

2. Non-elderly adults (18–64 years) had over twice the risk of dementia and MCI with gabapentin use compared to non-users.

3. The risk of cognitive decline increased with higher frequency of gabapentin prescriptions.

Evidence Rating Level: 2 (Good) 

This large retrospective cohort study investigated the association between gabapentin use and the development of dementia and mild cognitive impairment (MCI) in adults with chronic low back pain. Using deidentified data from the TriNetX national database spanning 2004 to 2024, the authors identified over 1.4 million eligible patients, ultimately including 26,416 gabapentin users and an equal number of matched controls after propensity score matching for demographics, comorbidities, and pain medications. Patients prescribed gabapentin six or more times after diagnosis were found to have significantly higher risks of both dementia (RR 1.29; 95% CI 1.18–1.40) and MCI (RR 1.85; 95% CI 1.63–2.10) within 10 years. The effect was more pronounced in non-elderly adults (18–64 years), with risk ratios exceeding 2.0, particularly in the 35–64 age group. A dose-response relationship was observed: those with 12 or more prescriptions had a higher incidence of both dementia and MCI than those with 3–11 prescriptions. The study concludes that gabapentin use in chronic low back pain is associated with increased risk of neurocognitive decline, and clinicians should be vigilant in monitoring long-term cognitive outcomes, especially in younger patients and those requiring prolonged therapy.

Click to read the study in RAPM

RELATED REPORTS

Higher peak expiratory flow associated with decreased headache risk in middle-aged and older adults

2 Minute Medicine Rewind August 18, 2025

Medical cannabis has a high discontinuation rate for treatment of musculoskeletal pain

Image: PD

©2025 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc. 

Tags: chronic paincognitive neurologydementiageriatric medicineneurology
Previous Post

New-generation antiseizure medications are better tolerated for patients with epilepsy

Next Post

MLC901 may be effective in treatment of post-concussion symptoms in phase III study

RelatedReports

Significant number of wrong-patient errors in radiology reports
Neurology

Higher peak expiratory flow associated with decreased headache risk in middle-aged and older adults

August 25, 2025
Few high school students, young adults get HIV testing
Weekly Rewinds

2 Minute Medicine Rewind August 18, 2025

August 24, 2025
Parental nonmedical prescription opioid use linked to adolescent use
Chronic Disease

Medical cannabis has a high discontinuation rate for treatment of musculoskeletal pain

August 15, 2025
Chronic Disease

Antiseizure medications do not reduce the risk of epilepsy in patients with brain abscess

August 9, 2025
Next Post
Quick Take: Effect of Pregabalin on Radiotherapy-Related Neuropathic Pain in Patients With Head and Neck Cancer: A Randomized Controlled Trial

MLC901 may be effective in treatment of post-concussion symptoms in phase III study

#VisualAbstract: Neoadjuvant and Adjuvant Pembroli-zumab Increased Survival in Locally Advanced Head and Neck Cancer

#VisualAbstract: Neoadjuvant and Adjuvant Pembroli-zumab Increased Survival in Locally Advanced Head and Neck Cancer

Predictors and outcomes associated with prolonged hospital length of stay in intracerebral hemorrhage

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Ciprofloxacin is non-inferior to aminoglycoside-ciprofloxacin for bubonic plague treatment
  • Finerenone with empagliflozin beneficial for managing CKD and type 2 diabetes
  • Catheter ablation improves cardiovascular prognosis in patients with atrial fibrillation compared to drug therapy
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.